Solaris Vaccines, a biotechnology company pioneering a novel approach to vaccine development, announced the appointment of Taru Dutt, PhD, as Director of Bacterial Countermeasures. This strategic addition strengthens...
In 2024, the University of Lausanne licensed its technology into i-Seq Biotechnology, Inc., a company formed by VIC Tech to advance novel, broad-spectrum vaccines and therapeutics against infectious disease pathogens...
Solaris Vaccines, a biotechnology company pioneering a novel approach to vaccine development, announced the addition of an accomplished scientist to its leadership team. Jonathan O. Rayner, PhD, joins as Chief...
The VIC Tech investment model is unique, sourcing promising life science innovations directly from universities nationwide. It provides funding to launch startup companies and advance these technologies, ultimately...
VIC Tech achieved key milestones in H1 2025, including portfolio advancements, strategic partnerships, and talent development. We remain focused on FDA submissions, clinical trials, and scaling initiatives to drive...
VIC Tech, a venture studio building life science companies from university and federal lab innovations, announced today the appointment of Virender “VK” Sharma, MD, to its Strategic Advisory Board (SAB). A recognized...
Introduction VIC Technology Venture Development is pleased to introduce the first installment in a new educational series on international market access for life science innovations. This white paper, developed by our...
In an industry where advanced degrees and technical titles often take center stage, Laura Lyons brings something just as powerful to the table; lived experience, heart, and a relentless drive to make life better for...
Fayetteville, AR – July 8, 2025 – Enhance Diagnostics, a clinical-stage company focused on non-invasive diagnostic solutions, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough...
Albuquerque, NM - Nob Hill Therapeutics (NHT) is pleased to announcethe addition of two prominent experts to its Strategic Advisory Board: Dr. Mark Parry-Billings, a seasoned biotech and pharmaceutical executive with...
FEATURED RESOURCES
